Skip to Content


Metastatic Colon Cancer Survival

Cancer Newsline - 4/6/09

Dr. Ray DuBois, MD Anderson's provost and executive vice president, talks with Dr. Scott Kopetz, assistant professor in MD Anderson's Department of Gastrointestinal Medical Oncology, about a new study that found novel chemotherapy and biological agents, combined with surgical advances for liver resection have resulted in a dramatic increase in survival for patients with metastatic colon cancer.

Guest(s):  Raymond N. DuBois, M.D., Ph.D., E. Scott Kopetz, M.D.

© 2015 The University of Texas MD Anderson Cancer Center